The Memory Disorders Program is currently recruiting for the following studies.
|Recruiting||An Efficacy and Safety Trial of MK-8931 in Mild to Moderate Alzheimer's Disease (P07738 AM3) (EPOCH)||Trial||Merck|
|Recruiting||Alzheimer's Disease Neuroimaging Initiative 2 (ADNI2)||Trial||ADCS|
|Recruiting||Multiple Dose Study of BIIB037 in Subjects With Prodromal or Mild Alzheimer's Disease||Trial||Biogen Idec|
For information on participating in our recruiting studies, please see Participating in Clinical Studies.